EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • March 23rd, 2023 • Erasca, Inc. • Pharmaceutical preparations • New York
This Exclusive License Agreement (this “Agreement”) is entered into as of December 9, 2022 (the “Effective Date”) by and between Novartis Pharma AG (“Novartis”), a corporation organized and existing under the laws of Switzerland, and Erasca, Inc., a corporation incorporated under the laws of the State of Delaware (“Erasca”). Erasca and Novartis are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
